Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis.
Ann Pharmacother. 1995 May;29(5):459-64. doi: 10.1177/106002809502900501.
Ann Pharmacother. 1995.
PMID: 7655127
Clinical Trial.